Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis

References

• Sundquist M, Brudin L, Tejler G. Improved survival in metastatic breast cancer 1985–2016. Breast. 2017;31:46–50. doi: 10.1016/j.breast.2016.10.005.
   PubMed Web of Science ®Google Scholar
• Rostami R, Mittal S, Rostami P, et al. Brain metastasis in breast cancer: a comprehensive literature review. J Neurooncol. 2016;127(3):407–414. doi: 10.1007/s11060-016-2075-3.
   PubMed Web of Science ®Google Scholar
• Sacks P, Rahman M. Epidemiology of brain metastases. Neurosurg Clin N Am. 2020;31(4):481–488. doi: 10.1016/j.nec.2020.06.001.
   PubMed Web of Science ®Google Scholar
• Tabouret E, Chinot O, Metellus P, et al. Recent trends in epidemiology of brain metastases: an overview. Anticancer Res. 2012;32:4655–4662.
   PubMed Web of Science ®Google Scholar
• Aversa C, Rossi V, Geuna E, et al. Metastatic breast cancer subtypes and Central nervous system metastases. Breast. 2014;23(5):623–628. doi: 10.1016/j.breast.2014.06.009.
   PubMed Web of Science ®Google Scholar
• Darlix A, Louvel G, Fraisse J, et al. Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort. Br J Cancer. 2019;121(12):991–1000. doi: 10.1038/s41416-019-0619-y.
   PubMed Web of Science ®Google Scholar
• Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system. J Clin Oncol. 2004;22(14):2865–2872. doi: 10.1200/JCO.2004.12.149.
   PubMed Web of Science ®Google Scholar
• Sim H-W, Morris PG, Patil S, et al. Brain metastases in breast cancer. Expert Rev Anticancer Ther. 2014;14(2):173–183. doi: 10.1586/14737140.2014.863468.
   PubMed Web of Science ®Google Scholar
• Komorowski AS, Warner E, MacKay HJ, et al. Incidence of brain metastases in nonmetastatic and metastatic breast cancer: is there a role for screening? Clin Breast Cancer. 2020;20(1):e54–e64. doi: 10.1016/j.clbc.2019.06.007.
   PubMed Web of Science ®Google Scholar
• Kuksis M, Gao Y, Tran W, et al. The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis. Neuro Oncol. 2021;23(6):894–904. doi: 10.1093/neuonc/noaa285.
   PubMed Web of Science ®Google Scholar
• Lukas RV, Gabikian P, Garza M, et al. Treatment of brain metastases. Oncology. 2014;87(6):321–329. doi: 10.1159/000362389.
   PubMed Web of Science ®Google Scholar
• Bailleux C, Eberst L, Bachelot T. Treatment strategies for breast cancer brain metastases. Br J Cancer. 2021;124(1):142–155. doi: 10.1038/s41416-020-01175-y.
   PubMed Web of Science ®Google Scholar
• Specht HM, Combs SE. Stereotactic radiosurgery of brain metastases. J Neurosurg Sci. 2016;60:357–366.
   PubMed Web of Science ®Google Scholar
• van Grinsven EE, Nagtegaal SHJ, Verhoeff JJC, et al. The impact of stereotactic or whole brain radiotherapy on neurocognitive functioning in adult patients with brain metastases: a systematic review and meta-analysis. Oncol Res Treat. 2021;44(11):622–636. doi: 10.1159/000518848.
   PubMed Web of Science ®Google Scholar
• Lippitz B, Lindquist C, Paddick I, et al. Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev. 2014;40(1):48–59. doi: 10.1016/j.ctrv.2013.05.002.
   PubMed Web of Science ®Google Scholar
• Gullhaug A, Hjermstad MJ, Yri O, et al. Use of radiotherapy in breast cancer patients with brain metastases: a retrospective 11-year single center study. J Med Imaging Radiat Sci. 2021;52(2):214–222. doi: 10.1016/j.jmir.2021.01.002.
   PubMed Web of Science ®Google Scholar
• Halasz LM, Uno H, Punglia RS. Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer: WBRT vs SRS for brain metastases. Cancer. 2016;122(20):3244–3245. doi: 10.1002/cncr.30009.
   PubMed Web of Science ®Google Scholar
• Wilson TG, Robinson T, MacFarlane C, et al. Treating brain metastases from breast cancer: outcomes after stereotactic radiosurgery. Clin Oncol. 2020;32(6):390–396. doi: 10.1016/j.clon.2020.02.007.
   Web of Science ®Google Scholar
• Caballero JA, Sneed PK, Lamborn KR, et al. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(1):303–309. doi: 10.1016/j.ijrobp.2011.06.1987.
   PubMed Web of Science ®Google Scholar
• Yang TJ, Oh JH, Folkert MR, et al. Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2014;90(3):518–525. doi: 10.1016/j.ijrobp.2014.06.063.
   PubMed Web of Science ®Google Scholar
• Li X, Yang J, Peng L, et al. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer. Breast Cancer Res Treat. 2017;161(2):279–287. doi: 10.1007/s10549-016-4059-6.
   PubMed Web of Science ®Google Scholar
• Kumar P, Aggarwal R. An overview of triple-negative breast cancer. Arch Gynecol Obstet. 2016;293(2):247–269. doi: 10.1007/s00404-015-3859-y.
   PubMed Web of Science ®Google Scholar
• Figura NB, Potluri TK, Mohammadi H, et al. CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases. J Neurooncol. 2019;144(3):583–589. doi: 10.1007/s11060-019-03260-6.
   PubMed Web of Science ®Google Scholar
• Lin NU, Borges V, Anders C, et al. Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2 − positive breast cancer with brain metastases in the HER2CLIMB trial. J Clin Oncol. 2020;38(23):2610–2619. doi: 10.1200/JCO.20.00775.
   PubMed Web of Science ®Google Scholar
• Lin NU, Diéras V, Paul D, et al. Multicenter phase II study of lapatinib in patients with brain metastases from HER2 − positive breast cancer. Clin Cancer Res. 2009;15(4):1452–1459. doi: 10.1158/1078-0432.CCR-08-1080.
   PubMed Web of Science ®Google Scholar
• Freedman RA, Gelman RS, Anders CK, et al. TBCRC 022: a phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2–positive breast cancer and brain metastases. J Clin Oncol. 2019;37(13):1081–1089. doi: 10.1200/JCO.18.01511.
   PubMed Web of Science ®Google Scholar
• Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363(9422):1665–1672. doi: 10.1016/S0140-6736(04)16250-8.
   PubMed Web of Science ®Google Scholar
• Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295(21):2483–2491. doi: 10.1001/jama.295.21.2483.
   PubMed Web of Science ®Google Scholar
• Medikonda R, Srivastava S, Kim T, et al. Development of new brain metastases in triple negative breast cancer. J Neurooncol. 2021;152(2):333–338. doi: 10.1007/s11060-021-03702-0.
   PubMed Web of Science ®Google Scholar
• Kennecke H, Yerushalmi R, Woods R, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28(20):3271–3277. doi: 10.1200/JCO.2009.25.9820.
   PubMed Web of Science ®Google Scholar
• Deluche E, Antoine A, Bachelot T, et al. Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016. Eur J Cancer. 2020;129:60–70. doi: 10.1016/j.ejca.2020.01.016.
   PubMed Web of Science ®Google Scholar
• Aoyama H, Tago M, Kato N, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007;68(5):1388–1395. doi: 10.1016/j.ijrobp.2007.03.048.
   PubMed Web of Science ®Google Scholar
• Brown PD, Ballman KV, Cerhan JH, et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18(8):1049–1060. doi: 10.1016/S1470-2045(17)30441-2.
   PubMed Web of Science ®Google Scholar
• Monaco EA, Faraji AH, Berkowitz O, et al. Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer: leukoencephalopathy after WBRT, not SRS. Cancer. 2013;119(1):226–232. doi: 10.1002/cncr.27504.
   PubMed Web of Science ®Google Scholar
• Duan L, Zeng R, Yang K-H, et al. Whole brain radiotherapy combined with stereotactic radiotherapy versus stereotactic radiotherapy alone for brain metastases: a meta-analysis. Asian Pac J Cancer Prev. 2014;15(2):911–915. doi: 10.7314/apjcp.2014.15.2.911.
   PubMedGoogle Scholar
• Kondziolka D, Kano H, Harrison GL, et al. Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer: clinical article. J Neurosurg. 2011;114(3):792–800. doi: 10.3171/2010.8.JNS10461.
   PubMed Web of Science ®Google Scholar
• Mills MN, Thawani C, Figura NB, et al. Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastases. J Neurooncol. 2021;152(3):591–601. doi: 10.1007/s11060-021-03735-5.
   PubMed Web of Science ®Google Scholar
• Vern-Gross TZ, Lawrence JA, Case LD, et al. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery. J Neurooncol. 2012;110(3):381–388. doi: 10.1007/s11060-012-0976-3.
   PubMed Web of Science ®Google Scholar
• Cho E, Rubinstein L, Stevenson P, et al. The use of stereotactic radiosurgery for brain metastases from breast cancer: Who benefits most? Breast Cancer Res Treat. 2015;149(3):743–749. doi: 10.1007/s10549-014-3242-x.
   PubMed Web of Science ®Google Scholar